Ahmedabad-based Cadila Pharmaceuticals recently inaugurated its state-of-the-art Active Pharmaceutical Ingredients (API) Plant at Dahej in the Bharuch district.
The facility, set up with an investment of Rs 200 crore, is equipped with the latest Distributed Control System (DCS) automation technology, marking a significant milestone in Cadila Pharmaceuticals’ dedication to innovation and excellence in drug manufacturing.
Dr H. G. Koshia, Food Drug Commissioner for Gujarat, and Dr M. P. Nakarani, Assistant Commissioner of FDCA, Baruch Circle, graced the event with their presence.
Speaking on the occasion, Biswajit Mitra, Chief Mentoring Officer at Cadila Pharmaceuticals and Convener Pharma Panel, CII Gujarat State, said, “The DCS technology used in this facility will allow us to produce APIs with a high level of purity and consistency, while also reducing the environmental impact. The implementation of the plant project will further extend our impact by generating employment opportunities for both permanent and contractual positions, thereby continuing our dedication to creating positive social change. ”
Cadila Pharmaceuticals had earlier signed an MoU with the government of Gujarat for investing Rs 1,000 crore in Gujarat. The Dahej API facility is one of the projects for which the MoU was signed.
The new API manufacturing facility will enable Cadila Pharmaceuticals to provide customers with the high-quality products they have come to expect from the company, while also helping it to expand its reach into new markets.
Comments powered by CComment